203 related articles for article (PubMed ID: 36949231)
1. A novel MYCN-YTHDF1 cascade contributes to retinoblastoma tumor growth by eliciting m
Luo Y; He M; Yang J; Zhang F; Chen J; Wen X; Fan J; Fan X; Chai P; Jia R
Sci China Life Sci; 2023 Sep; 66(9):2138-2151. PubMed ID: 36949231
[TBL] [Abstract][Full Text] [Related]
2.
Price EA; Patel R; Scheimberg I; Kotiloglu Karaa E; Sagoo MS; Reddy MA; Onadim Z
Ophthalmic Genet; 2021 Oct; 42(5):604-611. PubMed ID: 34003079
[No Abstract] [Full Text] [Related]
3. Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour.
Zhang H; Konjusha D; Rafati N; Tararuk T; Hallböök F
Cell Oncol (Dordr); 2024 Feb; 47(1):209-227. PubMed ID: 37606819
[TBL] [Abstract][Full Text] [Related]
4. An immature, dedifferentiated, and lineage-deconstrained cone precursor origin of N-Myc-initiated retinoblastoma.
Singh HP; Shayler DWH; Fernandez GE; Thornton ME; Craft CM; Grubbs BH; Cobrinik D
Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2200721119. PubMed ID: 35867756
[TBL] [Abstract][Full Text] [Related]
5. Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation.
Saengwimol D; Chittavanich P; Laosillapacharoen N; Srimongkol A; Chaitankar V; Rojanaporn D; Aroonroch R; Suktitipat B; Saisawang C; Svasti S; Hongeng S; Kaewkhaw R
Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):8. PubMed ID: 33270844
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
[TBL] [Abstract][Full Text] [Related]
8. MiR-142-5p serves as a tumor suppressor in retinoblastoma cells by regulating MYCN.
Li H; Fan D; Wang W; Zhang X; Song L; Huang Y
Biochem Biophys Res Commun; 2021 Oct; 574():20-26. PubMed ID: 34425282
[TBL] [Abstract][Full Text] [Related]
9. Secondary enucleated retinoblastoma with MYCN amplification.
Moulin AP; Stathopoulos C; Marcelli F; Schoumans Pouw J; Beck-Popovic M; Munier FL
Ophthalmic Genet; 2021 Jun; 42(3):354-359. PubMed ID: 33870828
[No Abstract] [Full Text] [Related]
10. A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence.
Wu N; Jia D; Bates B; Basom R; Eberhart CG; MacPherson D
J Clin Invest; 2017 Mar; 127(3):888-898. PubMed ID: 28165337
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.
Rushlow DE; Mol BM; Kennett JY; Yee S; Pajovic S; Thériault BL; Prigoda-Lee NL; Spencer C; Dimaras H; Corson TW; Pang R; Massey C; Godbout R; Jiang Z; Zacksenhaus E; Paton K; Moll AC; Houdayer C; Raizis A; Halliday W; Lam WL; Boutros PC; Lohmann D; Dorsman JC; Gallie BL
Lancet Oncol; 2013 Apr; 14(4):327-34. PubMed ID: 23498719
[TBL] [Abstract][Full Text] [Related]
12. MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation.
Qi DL; Cobrinik D
Oncogene; 2017 Mar; 36(13):1760-1769. PubMed ID: 27748758
[TBL] [Abstract][Full Text] [Related]
13. MRI Features for Identifying
Jansen RW; de Bloeme CM; Cardoen L; Göricke S; van Elst S; Jessen JL; Ramasubramanian A; Skalet AH; Miller AK; Maeder P; Uner OE; Hubbard GB; Grossniklaus H; Boldt HC; Nichols KE; Brennan RC; Sen S; Sirin S; Brisse HJ; Galluzzi P; Dommering CJ; Castelijns JA; van der Valk P; Boellaard R; Dorsman J; Moll AC; de Jong MC; de Graaf P
Radiology; 2023 Jun; 307(5):e222264. PubMed ID: 37191489
[TBL] [Abstract][Full Text] [Related]
14. LncRNA THOR acts as a retinoblastoma promoter through enhancing the combination of c-myc mRNA and IGF2BP1 protein.
Shang Y
Biomed Pharmacother; 2018 Oct; 106():1243-1249. PubMed ID: 30119193
[TBL] [Abstract][Full Text] [Related]
15. A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression.
Liu J; Ottaviani D; Sefta M; Desbrousses C; Chapeaublanc E; Aschero R; Sirab N; Lubieniecki F; Lamas G; Tonon L; Dehainault C; Hua C; Fréneaux P; Reichman S; Karboul N; Biton A; Mirabal-Ortega L; Larcher M; Brulard C; Arrufat S; Nicolas A; Elarouci N; Popova T; Némati F; Decaudin D; Gentien D; Baulande S; Mariani O; Dufour F; Guibert S; Vallot C; Rouic LL; Matet A; Desjardins L; Pascual-Pasto G; Suñol M; Catala-Mora J; Llano GC; Couturier J; Barillot E; Schaiquevich P; Gauthier-Villars M; Stoppa-Lyonnet D; Golmard L; Houdayer C; Brisse H; Bernard-Pierrot I; Letouzé E; Viari A; Saule S; Sastre-Garau X; Doz F; Carcaboso AM; Cassoux N; Pouponnot C; Goureau O; Chantada G; de Reyniès A; Aerts I; Radvanyi F
Nat Commun; 2021 Sep; 12(1):5578. PubMed ID: 34552068
[TBL] [Abstract][Full Text] [Related]
16. YTHDF1 promotes intrahepatic cholangiocarcinoma progression via regulating EGFR mRNA translation.
Huang X; Zhu L; Wang L; Huang W; Tan L; Liu H; Huo J; Su T; Zhang M; Kuang M; Li X; Dai Z; Xu L
J Gastroenterol Hepatol; 2022 Jun; 37(6):1156-1168. PubMed ID: 35233828
[TBL] [Abstract][Full Text] [Related]
17. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.
Liu T; Wei Q; Jin J; Luo Q; Liu Y; Yang Y; Cheng C; Li L; Pi J; Si Y; Xiao H; Li L; Rao S; Wang F; Yu J; Yu J; Zou D; Yi P
Nucleic Acids Res; 2020 Apr; 48(7):3816-3831. PubMed ID: 31996915
[TBL] [Abstract][Full Text] [Related]
18. Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular vesicles.
Shi C; Huang K; Soto J; Sankaran R; Kalia V; Onwumere O; Young M; Einbond L; Redenti S
Biomed Pharmacother; 2023 May; 161():114554. PubMed ID: 36940616
[TBL] [Abstract][Full Text] [Related]
19. RB1 gene inactivation by chromothripsis in human retinoblastoma.
McEvoy J; Nagahawatte P; Finkelstein D; Richards-Yutz J; Valentine M; Ma J; Mullighan C; Song G; Chen X; Wilson M; Brennan R; Pounds S; Becksfort J; Huether R; Lu C; Fulton RS; Fulton LL; Hong X; Dooling DJ; Ochoa K; Mardis ER; Wilson RK; Easton J; Zhang J; Downing JR; Ganguly A; Dyer MA
Oncotarget; 2014 Jan; 5(2):438-50. PubMed ID: 24509483
[TBL] [Abstract][Full Text] [Related]
20. Effect of CDK7 inhibitor on MYCN-amplified retinoblastoma.
Xu H; Xiao L; Chen Y; Liu Y; Zhang Y; Gao Y; Man S; Yan N; Zhang M
Biochim Biophys Acta Gene Regul Mech; 2023 Sep; 1866(3):194964. PubMed ID: 37536559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
